CYVNY — Opthea Ltd
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1815620 ·
Australia
Last close
$0.02
Market Cap
—
52W High
$3.41
52W Low
$0.00
ADV30
13,650
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | — | — | — | — | 145,770,000 | 131,916,000 | 314,475,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-711,622,000
Inventory
—
Receivables
$7,984,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,000 | -11,947,000 | 330,445,000 | 31,932,000 | 2,317,000 | 29,615,000 | — |
| Jun 2025 | 39,000 | -236,443,000 | -251,146,000 | 86,700,000 | 393,613,000 | -306,913,000 | — |
| Jun 2024 | 187,014 | -287,016,735 | -329,506,259 | 282,452,103 | 395,872,202 | -113,420,099 | -161,015,354 |
| Jun 2023 | 163,159 | -226,647,268 | -215,310,750 | 149,020,400 | 157,862,972 | -8,842,572 | -120,608,379 |
| Jun 2022 | — | — | — | — | — | — | -71,334,952 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $227.88B | $421.51 | — |
| GILD | GILEAD SCIENCES, INC. | $184.82B | $149.05 | — |
| MRNA | Moderna, Inc. | $76.88B | $192.57 | — |
| ARGX | ARGENX SE | $59.63B | $958.91 | — |
| RVMD | Revolution Medicines, Inc. | $43.99B | $205.26 | — |
Recent Insider Activity
No insider activity indexed for this ticker.